Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer.
We report a case of disseminated cutaneous Mycobacterium chelonae infection in a patient with head and neck cancer on salvage chemotherapy, including the epidermal growth factor receptor inhibitor cetuximab. Mycobacterium chelonae should be considered in the differential diagnosis of cutaneous infections in cancer patients receiving epidermal growth factor receptor inhibitors.
Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland,Ohio, USA.
Charles M
CM
Bark
Rana S
RS
Traboulsi
Kord
K
Honda
Autumn M
AM
Starnes
Michael R
MR
Jacobs
Benigno
B
Rodriguez
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001706:Biopsy; D000068818:Cetuximab; D005260:Female; D006258:Head and Neck Neoplasms / Q000150:complications* / Q000188:drug therapy*; D006651:Histocytochemistry; D006801:Humans; D008853:Microscopy; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000382:microbiology; D016926:Mycobacterium chelonae / Q000302:isolation & purification*; D012867:Skin / Q000473:pathology; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000382:microbiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab